• 1. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Aldehydes

Introduction to 3,5-dichloro-1H-Pyrrole-2,4-dicarboxaldehyde (CAS No. 152420-76-3) and Its Emerging Applications in Chemical Biology and Medicinal Chemistry

3,5-dichloro-1H-Pyrrole-2,4-dicarboxaldehyde, identified by its CAS number 152420-76-3, is a heterocyclic compound that has garnered significant attention in the fields of chemical biology and medicinal chemistry due to its versatile structural framework and potential biological activities. This compound belongs to the pyrrole derivatives family, which is well-known for its broad spectrum of pharmacological properties. The presence of both aldehyde functional groups and chlorine substituents at the 3rd and 5th positions, respectively, imparts unique reactivity and binding capabilities, making it a valuable scaffold for the development of novel therapeutic agents.

The structural features of 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde enable it to participate in diverse chemical reactions, including condensation, cyclization, and alkylation processes. These reactions are pivotal in the synthesis of more complex molecules, such as peptidomimetics and small-molecule inhibitors. In recent years, there has been a surge in research focusing on the development of pyrrole-based compounds due to their demonstrated efficacy in targeting various biological pathways. For instance, studies have highlighted the potential of this compound in modulating enzyme activity and interacting with specific protein receptors.

One of the most compelling aspects of 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde is its role as a key intermediate in the synthesis of bioactive molecules. Researchers have leveraged its reactive aldehyde groups to form Schiff bases and other conjugated systems that exhibit remarkable pharmacological properties. These derivatives have shown promise in preclinical studies as inhibitors of kinases and other enzymes implicated in cancer progression. The chlorine substituents further enhance the compound's binding affinity by allowing for hydrophobic interactions with target proteins.

Recent advancements in computational chemistry have also contributed to a deeper understanding of the interactions between 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde and biological targets. Molecular docking studies have revealed that this compound can effectively bind to pockets on enzymes such as tyrosine kinases and cyclin-dependent kinases (CDKs). These insights have guided the design of more potent analogs with improved selectivity and reduced toxicity. The integration of machine learning algorithms has further accelerated the discovery process by predicting optimal modifications to enhance binding affinity.

The compound's utility extends beyond enzyme inhibition; it has also been explored as a precursor in the synthesis of fluorescent probes for cellular imaging. Pyrrole derivatives are known for their ability to emit light upon excitation, making them valuable tools for visualizing biological processes in real-time. Researchers have developed 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde-based probes that selectively label specific intracellular components without causing significant toxicity. This application has opened new avenues in diagnostic imaging and drug delivery systems.

In addition to its biological applications, 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde has been investigated for its potential role in materials science. Its ability to form stable complexes with metals has led to the development of novel catalysts for organic transformations. These catalysts exhibit high efficiency and selectivity under mild reaction conditions, making them attractive for industrial processes. The compound's dual functionality as both an electron-withdrawing group (due to the aldehydes) and an electron-dispersing group (due to the chlorine atoms) allows for fine-tuning of reaction outcomes.

The synthesis of 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde itself is a testament to the ingenuity of synthetic chemists. Traditional methods involve multi-step reactions starting from commercially available pyrrole derivatives. Recent innovations have focused on greener synthetic routes that minimize waste and improve yields. For instance, catalytic methods using transition metals have been employed to achieve selective functionalization without harsh reagents or solvents. These advancements align with global efforts to promote sustainable chemistry practices.

The pharmacological potential of 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde has not gone unnoticed by pharmaceutical companies worldwide. Several drug discovery programs are currently underway investigating its derivatives as candidates for treating neurological disorders such as Alzheimer's disease and Parkinson's disease. Preliminary studies suggest that modifications at the 3rd and 5th positions can significantly alter pharmacokinetic properties while maintaining target specificity. This underscores the importance of structure-activity relationship (SAR) studies in optimizing lead compounds.

Another emerging area involves using 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde as a building block for covalent inhibitors targeting post-translational modifications (PTMs). PTMs play crucial roles in regulating protein function and are often dysregulated in diseases like cancer and inflammation. By designing molecules that covalently bind to modified residues on proteins, researchers aim to develop therapies that irreversibly inhibit pathological signaling pathways. The reactivity provided by the aldehyde groups makes this compound an ideal candidate for such applications.

The future prospects for 3,5-dichloro-1H-pyrrole-2,4-dicarboxaldehyde are promising given its multifaceted utility across multiple disciplines. As computational tools continue to evolve, so too will our ability to predict and design novel derivatives with tailored properties. Collaborative efforts between academia and industry are essential to translate laboratory findings into tangible therapeutic benefits for patients worldwide. The continued exploration of this compound will undoubtedly contribute significantly to advancements in chemical biology and medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)